Durabook Announces “Vanguard Partner Program” Enrichment to Channel Partners Program 
Home games nearly double the crowd: World Cup WiFi data shows what the quarter final is worth to UK pubs, so Purple is dressing their WiFi in the England flag for free Over 70% of Millennials Ready to Switch Banks for Better Savings APY, M1 Survey Finds
Only half of US Millennials think their primary financial institution will help them meet their…
Cabot Corporation Announces Executive Leadership Promotions
BOSTON–(BUSINESS WIRE)–Cabot Corporation (NYSE: CBT) is pleased to announce the promotions to Executive Vice President…
J.D. Power – LMC Automotive U.S. Automotive Forecast for December 2022
Up, Up and Up in December: New-Vehicle Sales Increase, Transaction Prices Hit Record High and…
Slate Asset Management Announces Partner and Managing Director Promotions
TORONTO–(BUSINESS WIRE)–Slate Asset Management (“Slate”), a global alternative investment platform targeting real assets, today announced…
Israel- Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute
U.S. Patent and Trademark Office extends protection of Clearmind’s proprietary MEAI and expands its potential…
Y-mAbs Announces Partnership Regarding Early Access Program for DANYELZA (naxitamab-gqgk) in Europe
NEW YORK, Dec. 21, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Update on First BioNTainer for African-based mRNA Manufacturing Facility
MAINZ, GERMANY, December 21, 2022 — BioNTech SE (Nasdaq: BNTX, “BioNTech”) reached the next milestone…
Healthy Extracts’ Whitney Johns Brain Activate ENERGY Gel Packs Now Available on Amazon.com
Brain Activate – ENERGY Gel Brain Activate – ENERGY Gel is a rapidly absorbed focus…
Sofwave Market Approvals For SUPERB™ Non-Invasive Wrinkle Reduction Technology Now Extend to Taiwan
Taiwan’s Food and Drug Administration, Division of Medical Devices and Cosmetics, grants Sofwave regulatory approval…
Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI
LEXINGTON, Mass., Dec. 21, 2022 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company…
Aerami Therapeutics Announces Completion of Dosing in Phase 1 Trial of AER-901 (inhaled imatinib), a Critical Milestone Toward the Planned Initiation of a Phase 2 Trial in Pulmonary Arterial Hypertension (PAH) During the First Half of 2023
AER-901 (inhaled imatinib), a potential reverse-remodeling therapy, is being developed to address unmet need for…
Vir Biotechnology Achieves Target Enrollment for Groundbreaking Phase 2 PENINSULA Trial Evaluating VIR-2482 for Prevention of Seasonal Influenza A
– Approximately 3,000 participants enrolled with initial trial data expected in mid-2023 – SAN FRANCISCO,…
Agios to Present at 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023
CAMBRIDGE, Mass., Dec. 21, 2022 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader…
Aerami Therapeutics Appoints Lisa Yañez as Chief Executive Officer
Ms. Yañez brings deep category experience and will lead Aerami’s focus on cardiopulmonary disease as…
Sutro Biopharma to Provide Data Update on STRO-002 and Plans for Registrational Path Forward in Advanced Ovarian Cancer
– Conference call and webcast to be held on Monday, January 9, 2023 at 1:30…
Akadeum Life Sciences Launches First of its Kind Product Benefitting Cell and Gene Therapy Research Following Successful Data from Early Access Program
Positive Results Spurs Launch of Akadeum’s Leukopak Isolation Kit citing speed, scalability, and cell recovery…
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation
SEATTLE, Wash and VANCOUVER, British Columbia, Dec. 21, 2022 (GLOBE NEWSWIRE) — Achieve Life Sciences,…
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19
Ji’an, Jiangxi, China, Dec. 21, 2022 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq:…
Motus GI Announces Improvement of Pure-Vu® EVS System for Use in Upper Gastrointestinal (GI) Bleeding Procedures Following Successful Pre-Clinical Tests
Pre-clinical tests show enhanced functionality of Pure-Vu EVS that can enable physicians to overcome common…
Elixirgen Therapeutics Appoints Jeffrey L. Cleland, Ph.D., to Board of Directors
BALTIMORE, Dec. 21, 2022 (GLOBE NEWSWIRE) — Elixirgen Therapeutics, Inc., a clinical-stage biotechnology company focused…